Clinical Trial Update: A Study of Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both [Phase 1]

View source ↗

Summary

Phase 1 trial in Asian patients with chronic hepatitis B evaluating early immunologic response to Pegasys or nucleoside analogues (or both); results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Nucleoside analogues
• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2016-01-13